• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非HFE型血色素沉着症、铁转运蛋白病及罕见遗传性铁过载疾病的诊断与管理

Diagnosis and Management of Non-HFE Hemochromatosis, Ferroportin Disease, and Rare Hereditary Iron-Loading Disorders.

作者信息

Pietrangelo Antonello

机构信息

Chief Internal Medicine Unit and Center for Hemochromatosis, Genomic Medicine & Rare Diseases, Italy, Modena.

出版信息

Adv Exp Med Biol. 2025;1480:131-143. doi: 10.1007/978-3-031-92033-2_10.

DOI:10.1007/978-3-031-92033-2_10
PMID:40603789
Abstract

Beyond the classic HFE-hemochromatosis, several genetic iron-loading disorders arise from mutations in genes regulating iron homeostasis, such as TFR2, HAMP, HJV, and the SLC40A1 (ferroportin) gene, as well as those involved in iron transport and mitochondrial function. These disorders lead to systemic or localized iron overload, resulting in complications such as liver disease, cardiomyopathy, endocrine dysfunction, and neurodegeneration. This chapter reviews the genetic basis, clinical presentations, and therapeutic approaches, emphasizing the importance of early diagnosis and intervention to mitigate organ damage and improve outcomes.

摘要

除了经典的HFE型血色素沉着症外,还有几种遗传性铁过载疾病是由调节铁稳态的基因突变引起的,如TFR2、HAMP、HJV和SLC40A1(铁转运蛋白)基因,以及那些参与铁运输和线粒体功能的基因。这些疾病会导致全身或局部铁过载,从而引发诸如肝病、心肌病、内分泌功能障碍和神经退行性变等并发症。本章回顾了其遗传基础、临床表现和治疗方法,强调了早期诊断和干预对于减轻器官损害和改善预后的重要性。

相似文献

1
Diagnosis and Management of Non-HFE Hemochromatosis, Ferroportin Disease, and Rare Hereditary Iron-Loading Disorders.非HFE型血色素沉着症、铁转运蛋白病及罕见遗传性铁过载疾病的诊断与管理
Adv Exp Med Biol. 2025;1480:131-143. doi: 10.1007/978-3-031-92033-2_10.
2
Current Landscape of Hepcidin Therapeutics.铁调素疗法的当前态势
Adv Exp Med Biol. 2025;1480:399-418. doi: 10.1007/978-3-031-92033-2_26.
3
The mechanisms of systemic iron homeostasis and etiology, diagnosis, and treatment of hereditary hemochromatosis.全身铁稳态机制以及遗传性血色素沉着症的病因、诊断和治疗
Int J Hematol. 2018 Jan;107(1):31-43. doi: 10.1007/s12185-017-2365-3. Epub 2017 Nov 13.
4
Hereditary hemochromatosis: mutations in genes involved in iron homeostasis in Brazilian patients.遗传性血色素沉着症:巴西患者铁稳态相关基因的突变。
Blood Cells Mol Dis. 2011 Apr 15;46(4):302-7. doi: 10.1016/j.bcmd.2011.02.008.
5
[Non-HFE-related hereditary iron overload].[非HFE相关的遗传性铁过载]
Presse Med. 2007 Sep;36(9 Pt 2):1279-91. doi: 10.1016/j.lpm.2007.01.042. Epub 2007 May 30.
6
Hereditary iron overload: update on pathophysiology, diagnosis, and treatment.遗传性铁过载:病理生理学、诊断和治疗的最新进展
Am J Hematol. 2006 Mar;81(3):202-9. doi: 10.1002/ajh.20493.
7
Clinicopathological study of Japanese patients with genetic iron overload syndromes.日本遗传性铁过载综合征患者的临床病理研究。
Pathol Int. 2012 Sep;62(9):612-8. doi: 10.1111/j.1440-1827.2012.02848.x.
8
Non-HFE hemochromatosis.非HFE型血色素沉着症
Semin Liver Dis. 2005 Nov;25(4):450-60. doi: 10.1055/s-2005-923316.
9
Non-HFE hepatic iron overload.非 HFE 相关性肝铁过载。
Semin Liver Dis. 2011 Aug;31(3):302-18. doi: 10.1055/s-0031-1286061. Epub 2011 Sep 7.
10
Molecular pathogenesis of hereditary hemochromatosis.遗传性血色素沉着症的分子发病机制
Histol Histopathol. 2016 Aug;31(8):833-40. doi: 10.14670/HH-11-762. Epub 2016 Mar 31.

本文引用的文献

1
Juvenile Hemochromatosis Connecting Cardiac Arrest and Hypogonadotropic Hypogonadism in a Young Woman.青少年血色素沉着症:一名年轻女性中心脏骤停与低促性腺激素性性腺功能减退的关联
JCEM Case Rep. 2024 Oct 24;2(11):luae196. doi: 10.1210/jcemcr/luae196. eCollection 2024 Nov.
2
Key players in the regulation of iron homeostasis at the host-pathogen interface.宿主-病原体界面中铁稳态调节的关键因素。
Front Immunol. 2023 Oct 24;14:1279826. doi: 10.3389/fimmu.2023.1279826. eCollection 2023.
3
Cellular iron governs the host response to malaria.
细胞铁调控宿主对疟疾的反应。
PLoS Pathog. 2023 Oct 9;19(10):e1011679. doi: 10.1371/journal.ppat.1011679. eCollection 2023 Oct.
4
Ferroportin Q248H mutation was not found to be protective against malaria and anemia in children under 5 years living in South Kivu/Democratic Republic of Congo, an endemic area of infection.在刚果民主共和国南基伍省这个感染流行地区,未发现铁转运蛋白Q248H突变对5岁以下儿童预防疟疾和贫血具有保护作用。
Heliyon. 2022 Aug 28;8(9):e10460. doi: 10.1016/j.heliyon.2022.e10460. eCollection 2022 Sep.
5
PIGA mutations (can) cause juvenile hemochromatosis.PIGA基因突变可导致青少年血色素沉着症。
Blood. 2022 Mar 3;139(9):1273-1275. doi: 10.1182/blood.2021014935.
6
Constitutional PIGA mutations cause a novel subtype of hemochromatosis in patients with neurologic dysfunction.体质性PIGA突变在伴有神经功能障碍的患者中导致一种新型血色素沉着症亚型。
Blood. 2022 Mar 3;139(9):1418-1422. doi: 10.1182/blood.2021013519.
7
Similar Ferroportin Q248H polymorphism prevalence in patients with Plasmodium falciparum malaria and control subjects in the low-endemic setting of Botswana.在博茨瓦纳低流行地区,恶性疟原虫疟疾患者和对照人群的铁蛋白 Q248H 多态性流行率相似。
Clin Chim Acta. 2021 Dec;523:77-80. doi: 10.1016/j.cca.2021.09.009. Epub 2021 Sep 14.
8
Pathogenic mechanism and modeling of neuroferritinopathy.神经铁蛋白病的发病机制与建模。
Cell Mol Life Sci. 2021 Apr;78(7):3355-3367. doi: 10.1007/s00018-020-03747-w. Epub 2021 Jan 13.
9
Structural basis of ion transport and inhibition in ferroportin.铁蛋白转运蛋白中离子转运和抑制的结构基础。
Nat Commun. 2020 Nov 10;11(1):5686. doi: 10.1038/s41467-020-19458-6.
10
Structure of hepcidin-bound ferroportin reveals iron homeostatic mechanisms.亚铁转运蛋白结合血红素肽的结构揭示了铁稳态的机制。
Nature. 2020 Oct;586(7831):807-811. doi: 10.1038/s41586-020-2668-z. Epub 2020 Aug 19.